152 related articles for article (PubMed ID: 34890096)
21. A critical appraisal of the ENLIST severity scale for erythema nodosum leprosum.
Kumar B; Mehta H; Narang T; Dogra S
PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010378. PubMed ID: 35472087
[No Abstract] [Full Text] [Related]
22. Bullous Erythema Nodosum Leprosum as the First Manifestation of Multibacillary Leprosy: A Rare Phenomenon.
Bakshi N; Rao S; Batra R
Am J Dermatopathol; 2017 Nov; 39(11):857-859. PubMed ID: 28763338
[TBL] [Abstract][Full Text] [Related]
23. Etanercept in erythema nodosum leprosum.
Santos JRS; Vendramini DL; Nery JADC; Avelleira JCR
An Bras Dermatol; 2017; 92(4):575-577. PubMed ID: 28954119
[TBL] [Abstract][Full Text] [Related]
24. [Study of erythema nodosum leprosum].
Nguyen VU
Ann Dermatol Venereol; 1994; 121(2):194-6. PubMed ID: 7979039
[TBL] [Abstract][Full Text] [Related]
25. A dissimulate presentation of histoid Hansen's disease in the form of erythema nodosum leprosum.
Pathania V; Oberoi B; Baveja S; Shelly D; Venugopal R; Shankar P
Int J Mycobacteriol; 2019; 8(2):208-210. PubMed ID: 31210170
[TBL] [Abstract][Full Text] [Related]
26. Erythema nodosum leprosum: reactional leprosy.
Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
[TBL] [Abstract][Full Text] [Related]
27. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
[TBL] [Abstract][Full Text] [Related]
28. Giant PPD reaction with positive QuantiFERON-TB Gold in a patient with lepromatous leprosy.
Murthy V; Horowitz HW; Pham VP; Levis WR
J Drugs Dermatol; 2012 Oct; 11(10):1151-2. PubMed ID: 23285712
[No Abstract] [Full Text] [Related]
29. Bullous Erythema Nodosum Leprosum masquerading as systemic onset juvenile idiopathic arthritis: A case report.
Pradhan S; Prasad Nayak B; Padhi T; Sethy M
Lepr Rev; 2015 Dec; 86(4):387-90. PubMed ID: 26964436
[No Abstract] [Full Text] [Related]
30. International workshop on erythema nodosum leprosum (ENL)--consensus report; the formation of ENLIST, the ENL international study group.
Walker SL; Saunderson P; Kahawita IP; Lockwood DN
Lepr Rev; 2012 Dec; 83(4):396-407. PubMed ID: 23614260
[No Abstract] [Full Text] [Related]
31. Erythema nodosum leprosum post-COVID-19 vaccination: endemic while pandemic.
Fachler T; Olshtain-Pops K; Horev L
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e505-e506. PubMed ID: 35224779
[No Abstract] [Full Text] [Related]
32. Clinicopathologic challenge.
Kawakami T; Tsutsumi Y; Mizoguchi M; Ishi N; Soma Y
Int J Dermatol; 2007 Apr; 46(4):348-9. PubMed ID: 17442070
[No Abstract] [Full Text] [Related]
33. [Bullous erythema nodosum leprosum. A case report in French Guiana].
Couppié P; Sainte-Marie D; About V; Heid E; Pradinaud R
Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
[TBL] [Abstract][Full Text] [Related]
34. [Thalidomide used by patients with erythema nodosum leprosum].
Valente Mdo S; Vieira JL
Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide.
Costa PDSS; Maciel-Fiuza MF; Kowalski TW; Fraga LR; Feira MF; Camargo LMA; Caldoncelli DIO; Silveira MIDS; Schuler-Faccini L; Vianna FSL
Mem Inst Oswaldo Cruz; 2022; 117():e220039. PubMed ID: 36383784
[TBL] [Abstract][Full Text] [Related]
36. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G
Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
[TBL] [Abstract][Full Text] [Related]
37. Lucio's phenomenon: A systematic literature review of definition, clinical features, histopathogenesis and management.
Frade MAC; Coltro PS; Filho FB; Horácio GS; Neto AA; da Silva VZ; Westin AT; Guimarães FR; Innocentini LMAR; Motta ACF; Farina JA
Indian J Dermatol Venereol Leprol; 2022; 88(4):464-477. PubMed ID: 34672479
[TBL] [Abstract][Full Text] [Related]
38. [Late diagnosis nodular lepromatous leprosy from the Peruvian Amazon, with development of a type 2 reaction].
Villegas-Chiroque M; Maldonado-Gómez W; Espino-Saavedra W; Ventura-Flores R
Rev Chilena Infectol; 2021 Oct; 38(5):707-712. PubMed ID: 35506839
[TBL] [Abstract][Full Text] [Related]
39. A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
Bathula S; Sardana K; Mathachan SR; Khurana A; Ahuja A; Paliwal P
Int J Dermatol; 2023 Jan; 62(1):48-55. PubMed ID: 35924464
[TBL] [Abstract][Full Text] [Related]
40. Can etanercept be an option in management of recurrent steroid-dependent erythema nodosum leprosum? A retrospective study of six patients.
Sahani MK; Asati DP; Kaur M; Patra S
Indian J Dermatol Venereol Leprol; 2022; 88(2):243-246. PubMed ID: 34877848
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
